✦ LIBER ✦

Population pharmacokinetics of adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF)

✍ Scribed by M.A. Batey; J.G. Wright; A. Azzabi; D.R. Newell; M.J. Lind; A.H. Calvert; A.V. Boddy

Book ID: 117658876
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 161 KB
Volume: 38
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(02)00024-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dose–response effect of adjuvant cycloph

Dose–response effect of adjuvant cyclophosphamide, methotrexate, 5-fluorouracil (CMF) in node-positive breast cancer

✍ M Colleoni; K Price; M Castiglione-Gertsch; A Goldhirsch; A Coates; J Lindtner; 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Low dose chemotherapy of metastatic brea

Low dose chemotherapy of metastatic breast cancer with cyclophosphamide, adriamycin, methotrexate, 5-fluorouracil (CAMF) versus sequential cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and adriamycin

✍ Richard H. Creech; Robert B. Catalano; David T. Harris; Paul F. Engstrom; Paul J 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 647 KB

Variability in the pharmacokinetics of c

Variability in the pharmacokinetics of cyclophosphamide, methotrexate and 5-fluorouracil in women receiving adjuvant treatment for breast cancer

✍ M. J. Moore, C. Erlichman, J. J. Thiessen… 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 449 KB

The CMF-regimen. Modulation of cyclophos

The CMF-regimen. Modulation of cyclophosphamide uptake and clearance by methotrexate and fluorouracil

✍ Ernst A. De Bruijn; Yi Geng; Jo Hermans; Oscar Driessen 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 French ⚖ 481 KB

Influence of the 2 antimetabolites used in the CMFregimen, methotrexate (MTX, M) and fluorouracil (FUra, F) on in vivo pharmacokinetics of orally administered cyclophosphamide (CY, c), were studied in WAG/Rij rats. Blood plasma concentrations of CY following oral administration were monitored in sin

The CMF-regimen. Toxicity patterns follo

The CMF-regimen. Toxicity patterns following stepwise combinations of cyclophosphamide, methotrexate and fluorouracil

✍ Ernst A. De Brulin; Oscar M.J. Driessen; Jo Hermans 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 614 KB

The contribution of the agents used in the CMF regimen, i.e.. cyclophosphamide (CY), methotrexate (MTX) and fluorouracil (FUra), to the development of toxicity was determined in tumor-bearing WAClRij rats. Data from untreated (U) rats were compared with data from rats treated with single-agent thera

The effect of postoperative and primary

The effect of postoperative and primary radiation therapy on delivered dose of adjuvant Cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) chemotherapy in breast cancer

✍ Jedd F. Levine; C. Norman Coleman; Richard S. Cox; Gordon R. Ray; William M. Rog 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 457 KB 👁 2 views

The dose of adjuvant chemotherapy for breast cancer may be an important factor in the success of the treatment program. In a retrospective analysis, the authors determined whether patients who were irradiated either postoperatively (N = 29) or as part of primary treatment (N = 13) received a lower d